Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)

NCT01710267 is registered in ClinicalTrials.gov with Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD as lead sponsor.

NCT NCT01710267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)
Lead sponsor
Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
December 31, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy